Phase 1 trial HMR code: 22-006

Phase 1

Completed

• Conditions: Healthy volunteers; Not Applicable

• Registration Number: ISRCTN34662787
• Lead Sponsor: Heptares Therapeutics (United Kingdom)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-07-25
• Study Completion: 2022-12-26
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 16

Inclusion Criteria

Healthy human volunteer

Exclusion Criteria

The sponsor has confirmed that the trial meets the criteria for deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended.

Study & Design

• Study Type: Interventional
• Study Design: Not specified